Variant report
Variant | nsv1041915 |
---|---|
Chromosome Location | chr10:96851448-96869694 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs74150772 | chr10:96855666-96855667 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs576485707 | chr10:96855667-96855668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539232336 | chr10:96855669-96855670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541808295 | chr10:96855714-96855715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188911691 | chr10:96855737-96855738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572692652 | chr10:96855817-96855818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530838301 | chr10:96855850-96855851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541399371 | chr10:96855857-96855858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572598593 | chr10:96855918-96855919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372752155 | chr10:96855930-96855931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10786186 | chr10:96855958-96855959 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs149763407 | chr10:96855986-96855987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533516387 | chr10:96855989-96855990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574901894 | chr10:96856004-96856005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10786187 | chr10:96856010-96856011 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs74715140 | chr10:96856015-96856016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10786188 | chr10:96856022-96856023 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs546267198 | chr10:96856039-96856040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559329823 | chr10:96856071-96856072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548996839 | chr10:96856078-96856079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192527244 | chr10:96856079-96856080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145719773 | chr10:96856088-96856089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148948933 | chr10:96856142-96856143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185571329 | chr10:96856145-96856146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11188179 | chr10:96856172-96856173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs59277980 | chr10:96856221-96856222 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs189230195 | chr10:96856250-96856251 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539205745 | chr10:96856286-96856287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553012302 | chr10:96856311-96856312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs367576569 | chr10:96856335-96856336 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181026318 | chr10:96856439-96856440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185860116 | chr10:96856453-96856454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555322699 | chr10:96856463-96856464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528100316 | chr10:96856483-96856484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575139514 | chr10:96856499-96856500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551341313 | chr10:96856500-96856501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571541734 | chr10:96856519-96856520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536817884 | chr10:96856551-96856552 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543845713 | chr10:96856552-96856553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78967886 | chr10:96856569-96856570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2094294 | chr10:96856611-96856612 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs752415 | chr10:96856628-96856629 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs188722433 | chr10:96856639-96856640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555720708 | chr10:96856650-96856651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377024819 | chr10:96856681-96856682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs752416 | chr10:96856685-96856686 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs752417 | chr10:96856695-96856696 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs561660051 | chr10:96856698-96856699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181153573 | chr10:96856726-96856727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550460816 | chr10:96856752-96856753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Colorectal cancer | 18645599 | CNVD |
Polyposis syndrome | 18645599 | CNVD |
Prostate cancer | 17245344 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21364760 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 24453001 | CNVD |
Breast cancer | 16608533 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:96855600-96856000 | Enhancers | Gastric | stomach |
2 | chr10:96855800-96856400 | Enhancers | Fetal Intestine Large | intestine |
3 | chr10:96855800-96856400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
4 | chr10:96856000-96856200 | Enhancers | Fetal Intestine Small | intestine |
5 | chr10:96856000-96856800 | Enhancers | Stomach Mucosa | stomach |
6 | chr10:96856000-96858200 | Enhancers | HepG2 | liver |
7 | chr10:96856200-96857200 | Weak transcription | Fetal Intestine Small | intestine |
8 | chr10:96856400-96857400 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
9 | chr10:96856400-96857600 | Weak transcription | Fetal Intestine Large | intestine |
10 | chr10:96856800-96857200 | Weak transcription | Stomach Mucosa | stomach |
11 | chr10:96857200-96858000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr10:96857200-96858200 | Enhancers | Fetal Intestine Small | intestine |
13 | chr10:96857200-96858200 | Enhancers | Stomach Mucosa | stomach |
14 | chr10:96857400-96858000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
15 | chr10:96857400-96858200 | Enhancers | Liver | Liver |
16 | chr10:96857600-96857800 | Enhancers | Gastric | stomach |
17 | chr10:96857600-96858200 | Enhancers | Fetal Intestine Large | intestine |
18 | chr10:96869000-96871600 | Enhancers | HepG2 | liver |